Article info
PDFCardiovascular medicine
Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A
- Correspondence to:
Dr Perry M Elliott
The Heart Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK; perry.elliott{at}uclh.nhs.uk
Citation
Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A
Publication history
- Accepted July 20, 2005
- First published August 5, 2005.
Online issue publication
February 14, 2006
Article Versions
- Previous version (5 August 2005).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Heart